Steven L. Fisher Buys 7,500 Shares of MAYVILLE ENGR C/SH (NYSE:MEC) Stock

Share on StockTwits

MAYVILLE ENGR C/SH (NYSE:MEC) Director Steven L. Fisher bought 7,500 shares of the business’s stock in a transaction that occurred on Tuesday, August 13th. The stock was purchased at an average cost of $12.02 per share, for a total transaction of $90,150.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of NYSE MEC opened at $12.76 on Thursday. MAYVILLE ENGR C/SH has a 12-month low of $11.16 and a 12-month high of $17.40. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.37 and a quick ratio of 0.80. The firm has a fifty day moving average of $13.72.

MAYVILLE ENGR C/SH (NYSE:MEC) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.15. The company had revenue of $145.13 million during the quarter, compared to analyst estimates of $144.43 million. On average, analysts forecast that MAYVILLE ENGR C/SH will post 1.21 earnings per share for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. acquired a new stake in MAYVILLE ENGR C/SH in the 2nd quarter valued at $25,000. Russell Investments Group Ltd. acquired a new stake in MAYVILLE ENGR C/SH in the 2nd quarter valued at $28,000. Tower Research Capital LLC TRC acquired a new stake in MAYVILLE ENGR C/SH in the 2nd quarter valued at $39,000. FNY Investment Advisers LLC acquired a new stake in MAYVILLE ENGR C/SH in the 2nd quarter valued at $59,000. Finally, Charles Schwab Investment Management Inc. acquired a new stake in MAYVILLE ENGR C/SH in the 2nd quarter valued at $181,000. Hedge funds and other institutional investors own 15.85% of the company’s stock.

Several research analysts recently weighed in on the company. Jefferies Financial Group assumed coverage on MAYVILLE ENGR C/SH in a research report on Monday, June 3rd. They issued a “buy” rating on the stock. UBS Group assumed coverage on MAYVILLE ENGR C/SH in a research report on Monday, June 3rd. They issued a “neutral” rating and a $17.00 target price on the stock. William Blair assumed coverage on MAYVILLE ENGR C/SH in a research report on Monday, June 3rd. They issued an “outperform” rating on the stock. Zacks Investment Research lowered MAYVILLE ENGR C/SH from a “hold” rating to a “sell” rating in a research report on Thursday, August 15th. Finally, Citigroup started coverage on MAYVILLE ENGR C/SH in a research report on Monday, June 3rd. They issued a “buy” rating on the stock. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the stock. MAYVILLE ENGR C/SH currently has an average rating of “Buy” and a consensus price target of $18.00.

About MAYVILLE ENGR C/SH

There is no company description available for Mayville Engineering Company Inc

Read More: Are we seeing the beginning of a new bubble?

Receive News & Ratings for MAYVILLE ENGR C/SH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAYVILLE ENGR C/SH and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Armada Hoffler Properties  & Nam Tai Property  Head-To-Head Review
Armada Hoffler Properties & Nam Tai Property Head-To-Head Review
Critical Comparison: Taro Pharmaceutical Industries  and Genmab A/S
Critical Comparison: Taro Pharmaceutical Industries and Genmab A/S
Critical Comparison: Jerash Holdings   versus Its Rivals
Critical Comparison: Jerash Holdings versus Its Rivals
Comparing Symantec  & Tyler Technologies
Comparing Symantec & Tyler Technologies
LegacyTexas Financial Group  Raised to Buy at BidaskClub
LegacyTexas Financial Group Raised to Buy at BidaskClub
Adverum Biotechnologies  PT Lowered to $8.00 at SunTrust Banks
Adverum Biotechnologies PT Lowered to $8.00 at SunTrust Banks


 
© 2006-2019 Zolmax.